• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用苏木精通道中细胞质峰度从组织学切片预测透明细胞肾细胞癌的生存率

Predicting Clear Cell Renal Cell Carcinoma Survival Using Kurtosis of Cytoplasm in the Hematoxylin Channel from Histology Slides.

作者信息

Wang Jun, Chen Jianhui, Jiang Liren, Wu Qi, Wang Dawei

机构信息

Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.

Department of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China.

出版信息

J Oncol. 2022 Jan 13;2022:7693993. doi: 10.1155/2022/7693993. eCollection 2022.

DOI:10.1155/2022/7693993
PMID:35069737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8776432/
Abstract

PURPOSE

Grade-dependent decrease of lipid storage in clear cell renal cell carcinoma (ccRCC) leads to morphology changes in HE sections. This study investigated the role of cytoplasmic features in frozen sections of ccRCC on prognosis using the digital pathology approach.

METHODS

We established an automatic pipeline that performed tumor region selection, stain vector normalization, nuclei segmentation, and feature extraction based on the pathologic data from Shanghai General Hospital and The Cancer Genome Atlas database. Extracted features were subjected to survival analysis.

RESULTS

Kurtosis of the cytoplasm in the hematoxylin channel was correlated with progression-free survival (HR 0.10, 95% CI: 0.04-0.24, =6.52 10) and overall survival (HR 0.11, 95% CI: 0.05-0.31, =1.72 10) in ccRCC, which outperformed other texture features in this analysis. Multivariate Cox regression analysis revealed that low kurtosis of cytoplasm in the hematoxylin channel was an independent predictor for a shorter progression-free survival time (=0.044) and overall survival time ( = 0.01). Kaplan-Meier survival analysis of progression-free survival and overall survival also showed a significantly worse prognosis in patients with low kurtosis of the cytoplasm in the hematoxylin channel (both < 0.0001). Lower kurtosis of cytoplasm in the hematoxylin channel was associated with higher pathologic grade, less cholesterol ester, and more mitochondrial DNA content.

CONCLUSION

Kurtosis of the cytoplasm in the hematoxylin channel predicts survival in clear cell renal cell carcinoma.

摘要

目的

透明细胞肾细胞癌(ccRCC)中脂质储存的分级依赖性降低导致苏木精-伊红(HE)切片出现形态学变化。本研究采用数字病理学方法探讨ccRCC冰冻切片中细胞质特征对预后的作用。

方法

我们基于上海交通大学医学院附属瑞金医院和癌症基因组图谱(TCGA)数据库的病理数据,建立了一个自动流程,用于进行肿瘤区域选择、染色向量归一化、细胞核分割和特征提取。对提取的特征进行生存分析。

结果

苏木精通道中细胞质的峰度与ccRCC的无进展生存期(风险比[HR]0.10,95%置信区间[CI]:0.04 - 0.24,P = 6.52×10⁻⁶)和总生存期(HR 0.11,95% CI:0.05 - 0.31,P = 1.72×10⁻⁴)相关,在该分析中其表现优于其他纹理特征。多变量Cox回归分析显示,苏木精通道中细胞质的低峰度是无进展生存期缩短(P = 0.044)和总生存期缩短(P = 0.01)的独立预测因素。无进展生存期和总生存期的Kaplan - Meier生存分析也显示,苏木精通道中细胞质峰度低的患者预后明显更差(两者P均<0.0001)。苏木精通道中细胞质较低的峰度与较高的病理分级、较少的胆固醇酯和较多的线粒体DNA含量相关。

结论

苏木精通道中细胞质的峰度可预测透明细胞肾细胞癌的生存情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/fa65af9544d1/JO2022-7693993.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/bde0a80d7f8c/JO2022-7693993.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/f50a6d1c0db3/JO2022-7693993.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/ab29cea159c7/JO2022-7693993.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/6f26d856e350/JO2022-7693993.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/57f0d0a004a8/JO2022-7693993.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/0961445e42db/JO2022-7693993.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/ef8173a145cc/JO2022-7693993.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/fa65af9544d1/JO2022-7693993.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/bde0a80d7f8c/JO2022-7693993.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/f50a6d1c0db3/JO2022-7693993.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/ab29cea159c7/JO2022-7693993.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/6f26d856e350/JO2022-7693993.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/57f0d0a004a8/JO2022-7693993.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/0961445e42db/JO2022-7693993.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/ef8173a145cc/JO2022-7693993.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cda/8776432/fa65af9544d1/JO2022-7693993.008.jpg

相似文献

1
Predicting Clear Cell Renal Cell Carcinoma Survival Using Kurtosis of Cytoplasm in the Hematoxylin Channel from Histology Slides.利用苏木精通道中细胞质峰度从组织学切片预测透明细胞肾细胞癌的生存率
J Oncol. 2022 Jan 13;2022:7693993. doi: 10.1155/2022/7693993. eCollection 2022.
2
Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.免疫组织化学染色法检测肌纤维连接蛋白在透明细胞肾细胞癌中的预后意义及其与表皮生长因子受体表达的关系。
Urol Oncol. 2019 Nov;37(11):812.e9-812.e16. doi: 10.1016/j.urolonc.2019.07.002. Epub 2019 Aug 14.
3
Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.嫌色性肾细胞癌的生存率是否优于透明细胞肾细胞癌?一项基于临床的队列研究和荟萃分析。
Int Urol Nephrol. 2016 Feb;48(2):191-9. doi: 10.1007/s11255-015-1161-3. Epub 2015 Nov 20.
4
Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.SR-BI 的上调促进了透明细胞肾细胞癌的进展,并可作为一种预后生物标志物。
BMC Cancer. 2018 Jan 22;18(1):88. doi: 10.1186/s12885-017-3761-z.
5
The Study of Clear Cell Renal Cell Carcinoma with MR Diffusion Kurtosis Tensor Imaging and Its Histopathologic Correlation.MR 扩散峰度张量成像在透明细胞肾细胞癌中的研究及其与组织病理学的相关性。
Acad Radiol. 2018 Apr;25(4):430-438. doi: 10.1016/j.acra.2017.10.016. Epub 2017 Nov 29.
6
Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.RUNX1在透明细胞肾细胞癌中的表达增加预示着预后不良。
PeerJ. 2019 Oct 2;7:e7854. doi: 10.7717/peerj.7854. eCollection 2019.
7
Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.Twist1 的细胞质表达与 EMT 相关转录因子有关,与肾透明细胞癌的较高分级和更差的无进展生存期相关。
Clin Exp Med. 2018 May;18(2):177-190. doi: 10.1007/s10238-017-0481-2. Epub 2017 Dec 4.
8
Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma.机器学习组织病理学图像特征在透明细胞肾细胞癌诊断和生存预测中的临床应用
Int J Cancer. 2021 Feb 1;148(3):780-790. doi: 10.1002/ijc.33288. Epub 2020 Sep 17.
9
ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.整合素α2β1(ITGA2B)和整合素α8(ITGA8)可预测透明细胞肾细胞癌患者的预后。
Tumour Biol. 2016 Jan;37(1):253-62. doi: 10.1007/s13277-015-3792-5. Epub 2015 Jul 22.
10
High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.细胞质中 p27(Kip1) 的高表达与肾透明细胞癌患者的癌症特异性生存预后较差相关。
BJU Int. 2012 May;109(10):1565-70. doi: 10.1111/j.1464-410X.2011.10649.x. Epub 2011 Oct 7.

引用本文的文献

1
Predicting Grade and Patient Survival in Renal Cancer Using Machine Learning Analysis of Nucleolar Prominence.利用核仁突出度的机器学习分析预测肾癌的分级和患者生存率。
Cancer Med. 2025 Sep;14(17):e71196. doi: 10.1002/cam4.71196.
2
A simple method based on qualitative MRI features for characterizing clear cell renal cell carcinoma in small renal masses: comparison with the clear cell likelihood score.一种基于定性MRI特征的小肾肿块中透明细胞肾细胞癌特征化简单方法:与透明细胞可能性评分的比较
Abdom Radiol (NY). 2025 Feb 19. doi: 10.1007/s00261-025-04844-9.

本文引用的文献

1
Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade.在透明细胞肾细胞癌中,嗜酸性特征与免疫检查点和血管生成阻断的治疗效果相关。
J Immunother Cancer. 2021 Sep;9(9). doi: 10.1136/jitc-2021-002922.
2
A Real-World, Population-Based Retrospective Analysis of Therapeutic Survival for Recurrent Localized Renal Cell Carcinoma After Nephrectomy.肾切除术后复发性局限性肾细胞癌治疗生存情况的真实世界、基于人群的回顾性分析
Front Oncol. 2021 Sep 8;11:693831. doi: 10.3389/fonc.2021.693831. eCollection 2021.
3
Partial versus radical nephrectomy in clinical T2 renal masses.
T2 期肾肿瘤的部分切除术与根治性切除术。
Int J Urol. 2021 Nov;28(11):1149-1154. doi: 10.1111/iju.14664. Epub 2021 Aug 11.
4
Local and Regional Recurrences of Clinically Localized Renal Cell Carcinoma after Nephrectomy: A 15 Year Institutional Experience with Prognostic Features and Oncologic Outcomes.肾细胞癌肾切除术后局部和区域复发的 15 年机构经验:预后特征和肿瘤学结果。
Urology. 2021 Aug;154:201-207. doi: 10.1016/j.urology.2021.03.038. Epub 2021 Apr 20.
5
Recurrence after radical and partial nephrectomy in high complex renal tumor using propensity score matched analysis.采用倾向评分匹配分析比较高复杂性肾肿瘤行根治性肾切除术与部分肾切除术的复发情况。
Sci Rep. 2021 Feb 3;11(1):2919. doi: 10.1038/s41598-021-82700-8.
6
Features of increased malignancy in eosinophilic clear cell renal cell carcinoma.嗜酸细胞透明细胞肾细胞癌恶性程度增高的特征。
J Pathol. 2020 Dec;252(4):384-397. doi: 10.1002/path.5532. Epub 2020 Sep 24.
7
Lysosomal acid lipase promotes cholesterol ester metabolism and drives clear cell renal cell carcinoma progression.溶酶体酸性脂肪酶促进胆固醇酯代谢,并驱动透明细胞肾细胞癌的进展。
Cell Prolif. 2018 Aug;51(4):e12452. doi: 10.1111/cpr.12452. Epub 2018 Mar 23.
8
HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism.低氧诱导因子通过抑制脂肪酸代谢促进 ccRCC 中的脂质沉积和癌症。
Nat Commun. 2017 Nov 24;8(1):1769. doi: 10.1038/s41467-017-01965-8.
9
Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌的脂质组学特征和相关转录组学特征。
Sci Rep. 2016 Jun 30;6:28932. doi: 10.1038/srep28932.
10
Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis.蛋白质组学和代谢组学联合分析揭示肾癌中与分级相关的代谢重编程
Cancer Res. 2015 Jun 15;75(12):2541-52. doi: 10.1158/0008-5472.CAN-14-1703. Epub 2015 May 7.